TITLE

Effects of Indomethacin on Viral Replication Markers in Asymptomatic Carriers of Hepatitis B: A Randomized, Placebo-Controlled Trial

AUTHOR(S)
Bahrami, Hossein; Daryani, Nasser E.; Haghpanah, Babak; Moayyeri, Alireza; Moghadam, Katayoon Fayaz; Mirmomen, Shahram; Kamangar, Farin
PUB. DATE
April 2005
SOURCE
American Journal of Gastroenterology;Apr2005, Vol. 100 Issue 4, p856
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVES: Previous studies have suggested some benefits of nonsteroidal antiinflammatory drugs (NSAIDs) use in patients with chronic viral hepatitis. We evaluated potential effects of indomethacin in asymptomatic carriers of hepatitis B surface antigen (HBsAg).DESIGN: Randomized, placebo-controlled, double-masked clinical trial.METHODS: One hundred and twelve patients who were confirmed to be HBsAg carriers for at least 6 months and had normal liver function tests, normal abdominal sonography, and no sign of cirrhosis were randomly assigned into two groups. One group (56 participants, mean age (±SD) 31.7 (±9.6) yr, 29 male, mean serum alanine aminotransferase (ALT) (±SD) 24.9 (±9.2)) received indomethacin capsules (25 mg) three times daily and the other group (56 participants, mean age (±SD) 33.8 (±10.2) yr, 33 male, mean serum ALT (±SD) 24.5 (±8.7)) took placebo capsules with identical package and appearance. All participants were under treatment for 6 months and were followed 3 months thereafter. Statistical analyses were performed both by intention-to-treat and on-treatment methods.RESULTS: Nine participants in the indomethacin group (16%) and 8 in the placebo group (14%) did not complete the trial. HBsAg seroconversion did not differ by treatment group (2 subjects in each group became seronegative). Hepatitis B virus DNA (HBV-DNA) became negative in sera of 7 participants in the indomethacin group but only in 1 in the placebo group (intention-to-treatp= 0.06; on-treatmentp= 0.03). Seroconversion of HBeAg to anti-HBe occurred only in 5 participants in the indomethacin group (intention-to-treatp= 0.06; on-treatmentp= 0.03). Adverse events included one case of hepatotoxicity and two cases of gastritis in the indomethacin group and one suspected gastritis in the placebo group.CONCLUSIONS: We suggest use of indomethacin only in the subgroup of asymptomatic HBsAg carriers who have detectable HBV-DNA or HBeAg in their sera.(Am J Gastroenterol 2005;100:856–861)
ACCESSION #
16433589

 

Related Articles

  • Interpreting Blood Results - Liver Function Tests. Credland, Nicola // Dermatological Nursing;Jun2014, Vol. 13 Issue 2, p42 

    No abstract available.

  • Amiodarone interaction.  // Reactions Weekly;9/22/2007, Issue 1170, p8 

    The article describes the case of a 73-year-old woman who developed elevated serum transaminase levels while receiving rosuvastatin and concomitant amiodarone. Laboratory tests revealed that her liver function values were increased. Rosuvastatin was discontinued because of a possible interaction...

  • HBsAg loss is not an ideal indicator for discontinuing treatment of HBeAg-negative chronic hepatitis B: a case report. Dong, Pei-ling; Zhang, Xin; Zhao, Wen-min; Ding, Hui-guo // Journal of Infection & Chemotherapy (Springer Science & Business;Dec2013, Vol. 19 Issue 6, p1188 

    We experienced a case of a 36-year-old married man who was found to be hepatitis B virus (HBV) positive at 23 years of age. His liver function was repeatedly abnormal in the past 13 years. In November 2007 he presented with fatigue. Laboratory tests showed serum alanine aminotransferase...

  • Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric Assay. Kwang Hyun Chung; Won Kim; Byeong Gwan Kim; Ho-Young Lee; Eunhyo Jin; Yuri Cho; Ji Yeon Seo; Hwi Young Kim; Yong Jin Jung; Ji Won Kim; Ji Bong Jeong; Kook Lae Lee // Gut & Liver;Sep2015, Vol. 9 Issue 5, p657 

    Background/Aims: Quantification of hepatitis B surface antigen (HBsAg) is an emerging serologic test and may be useful for identifying treatment strategies for chronic hepatitis B (CHB). This study aimed to evaluate HBsAg titers during the natural course of CHB and identify correlations between...

  • Normal in the blood, abnormal in the urine. Mehta, P.; Lukacs, M.; Abraham, S.M. // QJM: An International Journal of Medicine;Oct2012, Vol. 105 Issue 10, p1001 

    No abstract available.

  • ROLE OF ELASTOGRAPHY AS A SCREENING TEST IN DETECTING EARLY LIVER FIBROSIS IN PATIENTS WITH NORMAL LIVER ARCHITECTURE ON CONVENTIONAL ULTRASOUND. Qayyum, Aneeza; Shahid, Rahat; Rehman, Attiq Ur // Pakistan Armed Forces Medical Journal;Oct2016, Vol. 66 Issue 5, p641 

    Cirrhosis of liver is characterized by replacement of normal liver tissue by fibrosis, scar tissue and regenerative nodules. Clinical manifestations like ascites or splenomegaly help point to the diagnosis of cirrhosis but the early detection of fibrosis is not possible by simple grey scale...

  • Development of occult hepatitis B viral infection in pregnancy: implications for antenatal screening in women from endemic areas. Chang, Philip; Tu, Jeffrey; Chesterman, Antony; Kim, Robert; Robertson, Peter; Rawlinson, William D.; Riordan, Stephen M. // Obstetric Medicine (1753-495X);Sep2010, Vol. 3 Issue 3, p115 

    Occult hepatitis B virus (HBV) infection, manifest clinically by the presence of HBV deoxyribonucleic acid (HBV DNA) in peripheral blood in individuals who test negative for the HBV surface antigen (HBsAg), may occur in various clinical contexts, including under the influence of pharmacological...

  • Biochemical "liver function tests" Smellie, W, Stuart A.; Ryder, Stephen D. // BMJ: British Medical Journal (International Edition);9/2/2006, Vol. 333 Issue 7566, p481 

    The article looks at biochemical liver function tests. According to the article, raised transaminases warrant more testing and are most often caused by alcoholic or non-alcoholic fatty liver disease. The article discusses Gilbert's syndrome, isolated raised unconjugated bilirubin, hemolysis,...

  • The effect of green tea in normalization of liver function test in experimental liver injury. Dashti, A. A.; Saieh, F. H.; Jadaon, M. M.; Asfar, S. K.; Abdulsamad, A. M.; Al-Zaid, N. S.; Dashti, H. M. // Trace Elements & Electrolytes;2006 2nd Quuarter, Vol. 23 Issue 2, p113 

    Liver injury was induced by subcutaneous administration of thioacetamide (200 mg/kg/wt) and the plasma level of Zn and Cu along with alanine aminotransferase (Alt) and asparate aminotransferase (Ast) studied. Administration of green tea improved the plasma level of Zn, Cu and Cu/Zn ratio....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics